交易中 10-14 10:12:11 美东时间
-0.527
-1.58%
2021年8月,莫德纳(Moderna)股价站上484美元的历史高点,市值逼近2000亿美元,一度超过百年药企默沙东。彼时的资本市场相信,mRNA是人类医药史的...
08-22 12:14
TradingKey - Merck stock surged after its personalized mRNA cancer therapy met both Phase 3 melanoma endpoints. Strong Q2 sales and pipeline growth support MRK’s outlook.
08-20 02:27
The US FDA has approved Gilead Sciences' (GILD) Trodelvy (sacituzumab govitecan) as a first-line treatment as monotherapy and in combination with Merck's (MRK) Keytruda (pembrolizumab) for triple-nega...
06-25 04:37
Moderna (MRNA) snapped a six-session winning streak on Monday, with shares falling 6.10% to $60.06 in afternoon trading. Despite the decline, the stock has been one of the market's standout performers...
06-23 02:05
A US FDA advisory panel unanimously agreed that the benefits of Moderna's (MRNA) mRNA seasonal flu vaccine, mRNA-1010, outweigh the risks in individuals 50-75 years old. The agency's Vaccines and Rela...
06-19 05:00
U.S. vaccine maker Moderna (MRNA) is exploring investments in manufacturing facilities in Germany and is particularly interested in acquiring sites that rival BioNTech (BNTX) plans to shut down as par...
06-17 15:19
Moderna (MRNA) on Tuesday said that Ester Banque, a former senior executive at Zoetis (ZTS) and Bristol Myers (BMY), will join the company as chief commercial officer as part of organizational changes...
06-16 20:57